Anti-TVP23A monoclonal antibody

Pre-made anti-TVP23A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TVP23A/TVP23A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2211-Ab-1/ GM-Tg-hg-IP2211-Ab-2Anti-Human TVP23A monoclonal antibodyHuman
GM-Tg-rg-IP2211-Ab-1/ GM-Tg-rg-IP2211-Ab-2Anti-Rat TVP23A monoclonal antibodyRat
GM-Tg-mg-IP2211-Ab-1/ GM-Tg-mg-IP2211-Ab-2Anti-Mouse TVP23A monoclonal antibodyMouse
GM-Tg-cynog-IP2211-Ab-1/ GM-Tg-cynog-IP2211-Ab-2Anti-Cynomolgus/ Rhesus macaque TVP23A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2211-Ab-1/ GM-Tg-felg-IP2211-Ab-2Anti-Feline TVP23A monoclonal antibodyFeline
GM-Tg-cang-IP2211-Ab-1/ GM-Tg-cang-IP2211-Ab-2Anti-Canine TVP23A monoclonal antibodyCanine
GM-Tg-bovg-IP2211-Ab-1/ GM-Tg-bovg-IP2211-Ab-2Anti-Bovine TVP23A monoclonal antibodyBovine
GM-Tg-equg-IP2211-Ab-1/ GM-Tg-equg-IP2211-Ab-2Anti-Equine TVP23A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2211-Ab-1/ GM-Tg-hg-IP2211-Ab-2; GM-Tg-rg-IP2211-Ab-1/ GM-Tg-rg-IP2211-Ab-2;
GM-Tg-mg-IP2211-Ab-1/ GM-Tg-mg-IP2211-Ab-2; GM-Tg-cynog-IP2211-Ab-1/ GM-Tg-cynog-IP2211-Ab-2;
GM-Tg-felg-IP2211-Ab-1/ GM-Tg-felg-IP2211-Ab-2; GM-Tg-cang-IP2211-Ab-1/ GM-Tg-cang-IP2211-Ab-2;
GM-Tg-bovg-IP2211-Ab-1/ GM-Tg-bovg-IP2211-Ab-2; GM-Tg-equg-IP2211-Ab-1/ GM-Tg-equg-IP2211-Ab-2
Products NameAnti-TVP23A monoclonal antibody
Formatmab
Target NameTVP23A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TVP23A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2211-Ag-1Recombinant multi-species TV23A/ TVP23A/ FAM18A protein


    Target information

    Target IDGM-IP2211
    Target NameTVP23A
    Gene ID780776,383103,360467,710574,490009,101084846,100139027,100056589
    Gene Symbol and SynonymsFAM18A,RGD1566405,TVP23A,YDR084C
    Uniprot AccessionA6NH52
    Uniprot Entry NameTV23A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166676
    Target ClassificationN/A

    The target: TVP23A, gene name: TVP23A, also named as FAM18A, YDR084C. This gene encodes a membrane protein associated with the Golgi apparatus, which plays a crucial role in intracellular vesicular transport. The encoded protein is likely associated with the late (trans) Golgi compartments, which are involved in the delivery of secretory and membrane proteins to the endosome, lysosome or the plasma membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.